Growth Stocks Won't This Cheap for Long: 3 Fresh Picks to Watch
Momentum can flip quickly in growth stocks, but today some names look cheap for the upside potential. This guide high...
Using Index Level With Sentiment Indicators
Merging index levels with sentiment indicators can enhance conviction and risk controls. This piece provides actionable tips.
21,956 articles
Why I Can't Stop Buying This Popular ETF in 2026 and Beyond
A top dividend-focused ETF is delivering gains, but I refuse to stop buying. Here’s how the approach stays discipline...
Yield Hides Problem: XSHD Dividend Strains Income Outlook
XSHD's high-yield strategy faces a payout squeeze as distributions shrink while prices slide. The result: a 5%–7% yie...
Northwestern Mutual’s 2025 Planning Reveals Confidence Gap
Nearly half of American millionaires say their financial planning needs work, signaling a confidence gap even as weal...
Best Healthcare Stocks 2026: Top May Picks for Growth
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...
Fed’s 2026 Cutting Path Could Break PFFA’s 9.5% Yield
The Virtus InfraCap U.S. Preferred Stock ETF (PFFA) offers a 9.5% yield, backed by 188 holdings and modest leverage. ...
When 2022 Tore Through Markets, Health ETF Defied Trend
In 2022, the S&P 500 tumbled as inflation hung over markets, but healthcare ETFs held up better. This piece examines ...
NATO Defense Spending Just Reaches New Highs, ETFs in Focus
NATO defense budgets surged to fresh records as members commit to larger, longer-term modernization. Three ETFs offer...
If Rates Fall Further, Here’s What Happens to KRE
KRE has climbed on improving regional bank margins. If rates fall further, here’s how the scenario could shape earnin...
Real Dividend Growth Exists in Small Caps, Unexpectedly
A wave of real income is emerging in select small-cap stocks, not in the obvious dividend leaders. Analysts say real ...
Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Cathie Wood's Private Equity Fund Nears $1B as SpaceX Buzz Grows
Private equity is moving from wall street legends to the everyday investor. Here’s how cathie wood's private equity i...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status